WCNDD Advances TREK Channel Drug Discovery Through Industry Collaboration
The Warren Center for Neuroscience Drug Discovery (WCNDD) has partnered with Ono Pharmaceutical Co., Ltd. to develop novel compounds targeting TREK channels—key regulators of neuronal excitability and pain signaling. This collaboration exemplifies the power of academic-industry partnerships in accelerating neuroscience innovation and advancing new therapeutic strategies for neurological and psychiatric disorders.